Partha Sardar1, Amartya Kundu2, Saurav Chatterjee3, Anju Nohria4, Ramez Nairooz5, Sripal Bangalore6, Debabrata Mukherjee7, Wilbert S Aronow8, Carl J Lavie9. 1. Division of Cardiovascular Medicine, University of Utah, Salt Lake City. 2. Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts. 3. St Luke's-Roosevelt Hospital of the Mount Sinai Health System, New York, New York. 4. Department of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 5. University of Arkansas for Medical Sciences, Little Rock, Arkansas. 6. New York University School of Medicine, New York, New York. 7. Texas Tech University Health Sciences Center, El Paso, Texas. 8. New York Medical College, Valhalla, New York. 9. John Ochsner Heart and Vascular Institute, Ochsner Clinical School/University of Queensland School of Medicine, New Orleans, Louisiana.
Abstract
BACKGROUND: Radiotherapy (RT) is frequently associated with late cardiovascular (CV) complications. The mean cardiac dose from irradiation of a left-sided breast cancer is much higher than that for a right-sided breast cancer. However, data is limited on the long-term risks of RT on CV mortality. HYPOTHESIS: RT for breast cancer is associated with long term CV mortality and left sided RT carries a greater mortality than right sided RT. METHODS: We searched PubMed, Cochrane Central, Embase, EBSCO, Web of Science, and CINAHL databases from inception through December 2015. Studies reporting CV mortality with RT for left- vs right-sided breast cancers were included. The principal outcome of interest was CV mortality. We calculated summary risk ratio (RR) and 95% confidence intervals (CI) with the random-effects model. RESULTS: The analysis included 289 109 patients from 13 observational studies. Women who had received RT for left-sided breast cancer had a higher risk of CV death than those who received RT for a right-sided breast cancer (RR: 1.12, 95% CI: 1.07-1.18, P < 0.001; number needed to harm: 353). Difference in CV mortality between left- vs right-sided breast RT was more apparent after 15 years of follow-up (RR: 1.23, 95% CI: 1.08-1.41, P < 0.001; number needed to harm: 95). CONCLUSIONS: CV mortality from left-sided RT was significantly higher compared with right-sided RT for breast cancer and was more apparent after ≥15 years of follow-up.
BACKGROUND: Radiotherapy (RT) is frequently associated with late cardiovascular (CV) complications. The mean cardiac dose from irradiation of a left-sided breast cancer is much higher than that for a right-sided breast cancer. However, data is limited on the long-term risks of RT on CV mortality. HYPOTHESIS: RT for breast cancer is associated with long term CV mortality and left sided RT carries a greater mortality than right sided RT. METHODS: We searched PubMed, Cochrane Central, Embase, EBSCO, Web of Science, and CINAHL databases from inception through December 2015. Studies reporting CV mortality with RT for left- vs right-sided breast cancers were included. The principal outcome of interest was CV mortality. We calculated summary risk ratio (RR) and 95% confidence intervals (CI) with the random-effects model. RESULTS: The analysis included 289 109 patients from 13 observational studies. Women who had received RT for left-sided breast cancer had a higher risk of CV death than those who received RT for a right-sided breast cancer (RR: 1.12, 95% CI: 1.07-1.18, P < 0.001; number needed to harm: 353). Difference in CV mortality between left- vs right-sided breast RT was more apparent after 15 years of follow-up (RR: 1.23, 95% CI: 1.08-1.41, P < 0.001; number needed to harm: 95). CONCLUSIONS: CV mortality from left-sided RT was significantly higher compared with right-sided RT for breast cancer and was more apparent after ≥15 years of follow-up.
Authors: Katherine A Vallis; Melania Pintilie; Nelson Chong; Eric Holowaty; Pamela S Douglas; Peter Kirkbride; Andreas Wielgosz Journal: J Clin Oncol Date: 2002-02-15 Impact factor: 44.544
Authors: A Gustavsson; P O Bendahl; M Cwikiel; J Eskilsson; K L Thapper; O Pahlm Journal: Int J Radiat Oncol Biol Phys Date: 1999-03-01 Impact factor: 7.038
Authors: Sharon H Giordano; Yong-Fang Kuo; Jean L Freeman; Thomas A Buchholz; Gabriel N Hortobagyi; James S Goodwin Journal: J Natl Cancer Inst Date: 2005-03-16 Impact factor: 13.506
Authors: D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker Journal: JAMA Date: 2000-04-19 Impact factor: 56.272
Authors: Zhanat A Carr; Charles E Land; Ruth A Kleinerman; Robert W Weinstock; Marilyn Stovall; Melvin L Griem; Kiyohiko Mabuchi Journal: Int J Radiat Oncol Biol Phys Date: 2005-03-01 Impact factor: 7.038
Authors: Alejandro Santos-Lozano; Javier Ramos; Alejandro Alvarez-Bustos; Blanca Cantos; Lidia B Alejo; Itziar Pagola; Ana Soria; Constanza Maximiano; Carmen Fiuza-Luces; Luisa Soares-Miranda; Alejandro Lucia; Ana Ruiz-Casado Journal: Support Care Cancer Date: 2018-02-05 Impact factor: 3.603
Authors: Médéa Locquet; Daan Spoor; Anne Crijns; Pim van der Harst; Arantxa Eraso; Ferran Guedea; Manuela Fiuza; Susana Constantino Rosa Santos; Stephanie Combs; Kai Borm; Elie Mousseaux; Umit Gencer; Guy Frija; Elisabeth Cardis; Hans Langendijk; Sophie Jacob Journal: Front Oncol Date: 2022-06-28 Impact factor: 5.738
Authors: Sanjay Divakaran; Jesse P Caron; Wunan Zhou; Jon Hainer; Courtney F Bibbo; Hicham Skali; Viviany R Taqueti; Sharmila Dorbala; Ron Blankstein; John D Groarke; Anju Nohria; Marcelo F Di Carli Journal: J Nucl Cardiol Date: 2021-11-24 Impact factor: 3.872
Authors: Heather Greenlee; Carlos Iribarren; Jamal S Rana; Richard Cheng; Mai Nguyen-Huynh; Eileen Rillamas-Sun; Zaixing Shi; Cecile A Laurent; Valerie S Lee; Janise M Roh; Margarita Santiago-Torres; Hanjie Shen; Dawn L Hershman; Lawrence H Kushi; Romain Neugebauer; Marilyn L Kwan Journal: J Clin Oncol Date: 2022-04-06 Impact factor: 50.717
Authors: Amy M Berkman; J A Livingston; Kelly Merriman; Michelle Hildebrandt; Jian Wang; Seyedeh Dibaj; Jennifer McQuade; Nancy You; Anita Ying; Carlos Barcenas; Diane Bodurka; April DePombo; Hun Ju Lee; John de Groot; Michael Roth Journal: Cancer Date: 2020-06-02 Impact factor: 6.860